Three upward arrows next to text: Stand Up To Cancer, Scientific Summit 2027. Bold black, red, and orange colors.

Scientific

Summit 2027

  • February 3 – February 6, 2027
2026: Celebrating Groundbreaking Research

Scientific Summit 2026 Transition to Virtual

Since the beginning of Stand Up To Cancer, the annual SU2C Scientific Summit has brought the SU2C community together for spontaneous conversations across topics driven by our active cancer research portfolio, leading to new ideas and collaborations. We were extremely excited about gathering in Pasadena, California.

This year, we have been met with challenges presented by the ongoing fires in the Los Angeles area.

Julian Adams, Ph.D.
President, CEO - SU2C

Read More
SU2C Science Year in Review
🔍
Download PDF

Knowledge Expansion

Gain insights into cutting-edge research and advancements in your field.

Networking Opportunities

Connect with peers, researchers, and industry professionals for collaboration.

Inspiration

Get inspired by keynote speakers, presentations, and workshops that challenge and motivate!

2026 Schedule

Come ready for an inspiring, high-energy experience where innovation thrives, collaborations ignite, and the path to new cures becomes clearer than ever.

JAN
29

Thursday,
January 29

Two Innovation Summits, Reviews, Poster Session

JAN
30

Friday,
January 30

Plenary Session, Dinner Event

JAN
31

Saturday,
January 31

Three Innovation Summits

FEB
1

Sunday,
February 1

SU2C SAC Meeting

View Full Schedule

New This Year:
Innovation Summits!

Supercharge your Scientific Summit experience with our brand-new Innovation Summits — high-impact, deep-dive sessions on the cutting edge of science and innovation. These add-on sessions are your chance to go beyond the main stage and explore what’s next in your field.

Each Innovation Summit is offered at a specific time, and with multiple options running simultaneously, you'll need to pick the one(s) that excites you most — no double booking! Spots are limited, so be sure to reserve your seat early. Let the innovation begin!

SU2C Innovation Summit

Early Detection, Screening, and Treatment for Anal and Oropharyngeal Cancers

  • Thursday, January 29, 2026
  • 8:00 AM - 2:45 PM
  • The Langham Huntington - Georgian Ballroom
  • Moderator: Lawrence D. Piro, MD
Logo of the Farrah Fawcett Foundation featuring a pink heart outline and the organizations name in bold black text.
  • Stand Up To Cancer (SU2C) will be the engine to convene researchers focusing on topics related to early detection, screening, and treatment for HPV-related tumor in the anus and oropharynx at an in-person Innovation Summit in early 2026. The best way to combat cancers and to accelerate impactful outcomes is through the power of collaboration. Collaboration has been a cornerstone of SU2C since day one.
  • The goal of the Innovation Summit is to have the most cutting-edge researchers brainstorm to bring the best ideas forward for what will ultimately achieve the greatest benefit to the anal and oropharyngeal cancers population.
  • Post-summit, SU2C will distribute an RFA, and ultimately, we will launch a dedicated Research Team on early detection, screening, and treatment for anal and oropharyngeal cancers.
  • When we all come together, anal and oropharyngeal cancers don’t stand a chance.
SU2C Innovation Summit

Advancing the Use of Theranostics in Cancer Care

  • Thursday, January 29, 2026
  • 8:00 AM - 2:45 PM
  • The Langham Huntington - Huntington Ballroom II & III
  • Moderator: TBD
  • Text coming soon.
SU2C Innovation Summit

Translating Data to the Limits of Detection

  • Saturday, January 31, 2026
  • 8:00 AM - 6:30 PM
  • The Langham Huntington - Georgian Ballroom
  • Moderator: Peter Sorger, PhD
  • Stand Up To Cancer (SU2C) will convene researchers focusing on topics related to detecting cancer as early as possible at an in-person Innovation Summit in early 2026. The best way to combat cancers and to accelerate impactful outcomes is through the power of collaboration. Collaboration has been a cornerstone of SU2C since day one.
  • The goal of the Innovation Summit is to have the most cutting-edge researchers brainstorm to bring the best ideas forward for what will ultimately achieve the greatest benefit to all patients.
  • The overall programmatic goal is to fund translational trials for early detection of cancer, enabled by AI. Questions to consider include: How do we optimize data collection and analysis for the purpose of early-stage detection particularly of pre-invasive and early solid cancers (Stages 0 and 1)? What determines the limits of detection with respect to molecules or cells and the tradeoff between sensitivity and specificity? How do we increase the ability of assays and AI to pick up the tiniest signals using (i) specimens we already collect, (ii) specimens we might collect in the future, and (iii) non-invasive methods? Finally, how might such data be optimally used in patient care, balancing the risks of both under and over-treatment?
  • Post-summit, SU2C will work with funding collaborators to prepare and distribute an RFA, and ultimately, we will launch a dedicated Early Detection Research Team(s) co-branded with the participating funding organizations.
  • When we all come together, cancer don’t stand a chance.
SU2C Innovation Summit

Breakthrough Pathways in Malignant Glioma

  • Saturday, January 31, 2026
  • 8:00 AM - 6:30 PM
  • The Langham Huntington - Huntington Ballroom II & III
  • Moderator: Scott Armstrong, MD, PhD
  • Stand Up To Cancer (SU2C) will be the engine to convene the best and brightest in the world of malignant glioma research at an in-person Innovation Summit in early 2026 in an effort towards defining breakthough pathways for detection and treatment of glioblastoma. We know the best way to combat this disease and accelerate impactful glioblastoma treatment is through the power of collaboration. Collaboration has been a cornerstone of SU2C since day one.
  • The goal of the Innovation Summit is to have the most cutting-edge researchers brainstorm to bring the best ideas forward for what will ultimately achieve the greatest benefit to glioblastoma patients, children and young adult (CAYA) patients as well as adult patients.
  • Post-summit, SU2C will distribute an RFA, and ultimately, we will launch a dedicated glioblastoma Dream Team with the potential to cure glioblastoma cancer following the game-changing criteria required and co-branded with the participating funding organizations.
  • We are coming together to discuss how to cure glioblastoma. Patient Advocates are here to share their journeys to guide participants towards options which will be feasible for patients and to outreach with others about the upcoming RFA to aid in bringing the most promising options forward to consider for funding. Researchers are here to identify the most promising options for patients and afterwards to guide the academic research moving forward. Nonprofits are here to share outcomes from research funded which has high impact for glioblastoma patients and to consider coming together with SU2C and other funders towards a larger scale initiative. Companies are here to share information about their research and pipeline towards promising outcome of glioblastoma patients and to consider donating assets and funds towards this large-scale research initiative.
  • When we all come together, glioblastoma doesn’t stand a chance.
SU2C Innovation Summit

Approaches Towards Detecting and Treating Early Onset Cancers

  • Saturday, January 31, 2026
  • 8:00 AM - 6:30 PM
  • The Langham Huntington - Viennese Ballroom
  • Moderator: Kimryn Rathmall, MD, PhD, MMHC
  • Stand Up To Cancer (SU2C) will convene researchers focusing on topics related to early onset cancers at an in-person Innovation Summit in early 2026. The best way to combat cancers and to accelerate impactful outcomes is through the power of collaboration. Collaboration has been a cornerstone of SU2C since day one.
  • The goal of the Innovation Summit is to have the most cutting-edge researchers brainstorm to bring the best ideas forward for what will ultimately achieve the greatest benefit to the patients experiencing cancer at young ages.
  • The overall programmatic goal is to fund translational trials for early prevention and detection of early onset cancers. Screening, liquid biopsy, nutrition intervention, novel therapeutics in certain high-risk populations, and use of AI tools for risk stratification are examples of ideas to consider. Questions to consider include: How to build tools for use in the clinic? How to apply tools to this clinical problem? What’s ready for translation in terms of new diagnostics and/or therapeutics?
  • Post-summit, SU2C will work with funding collaborators to prepare and distribute an RFA, and ultimately, we will launch a dedicated Research Team on early onset cancers co-branded with the participating funding organizations.
  • When we all come together, cancer don’t stand a chance.
Leaders in Science

Featured Speakers

We are honored to introduce our distinguished guest speakers for this year's SU2C Scientific Summit 2026.

Dr. Julian Adams, PhD President, CEO – SU2C
Dr. Julian Adams, PhD President, CEO – SU2C
Image (4)
John Doe CEO
Image (4)
John Doe CEO
Image (4)
John Doe CEO
Image (4)
John Doe CEO
View all of our speakers
Ready to engage?

Register for the SU2C Scientific Summit 2026

This SU2C Scientific Summit 2026 promises to be another exciting opportunity to convene for updates on the scientific achievements of the various SU2C-funded projects and explore collaborations! In attendance will be SU2C Scientific Advisory Committee members, reviewers of the SU2C projects, SU2C grantees, as well as representatives from Stand Up To Cancer’s funding collaborators.

Register Today
  • Check
    Knowledge Expansion
  • Check
    Networking Opportunities
  • Check
    Inspiration

Agenda - Saturday, January 31, 2026

7:00 a.m. – 7:45 a.m.
Breakfast
TBD

7:45 a.m. – 8:00 a.m.
Break and Transfer to SU2C Innovation Summits

8:00 a.m. – 6:30 p.m.
SU2C Innovation Summit: Approaches Towards Detecting and Treating Early Onset Cancers
TBD

8:00 a.m. – 6:30 p.m.
SU2C Innovation Summit: Breakthrough Pathways in Malignant Glioma
TBD

8:00 a.m. – 6:30 p.m.
SU2C Innovation Summit: Translating Data to the Limits of Detection
TBD

6:30 p.m. – 7:00 p.m.
Break and Transfer to Dinner

7:00p.m. – 9:00 p.m.
Dinner

Agenda - Thursday, January 29, 2026

7:00 a.m. – 7:45 a.m.
Breakfast
Huntington Ballroom I

7:45 a.m. – 8:00 a.m.
Break and Transfer to SU2C Innovation Summits

8:00 a.m. – 2:45 p.m.
SU2C Innovation Summit: Early Detection, Screening, and Treatment for Anal and Oropharyngeal Cancers
Viennese Ballroom

8:00 a.m. – 2:45 p.m.
SU2C Innovation Summit: Advancing the Use of Theranostics in Cancer Care
Huntington Ballroom II & III